In the past several years, the United States has witnessed a remarkable surge in investments from pharmaceutical giants as they seek to expand drug manufacturing facilities on American soil. This ambitious shift is largely influenced by geopolitical uncertainties and evolving market dynamics. A
The recent wave of investments by major biotech companies into U.S. manufacturing capabilities marks a pivotal movement, reshaping the landscape of the pharmaceutical industry. These corporations are strategically enhancing domestic production to mitigate risks associated with global supply chains
Stevanato Group’s strategic expansion into the U.S. with a significant investment in syringe production marks a pivotal moment in the biopharmaceutical landscape. Located in Fishers, Indiana, this Italian company has strategically aligned itself with the growing demands of biologics, making notable
In this insightful discourse, we have the privilege of speaking with Kwame Zaire, a renowned expert in manufacturing with a keen focus on the electronics and equipment industry. Kwame brings a wealth of knowledge on production management, predictive maintenance, quality, and safety. Today, we delve
Varda Space Industries has announced a significant milestone in its pursuit of revolutionizing the pharmaceutical industry through space-based drug production. The company secured an astounding $187 million in recent funding led by Natural Capital and Shrug Capital, with support from Lux Capital,
With a dynamic and rapidly evolving pharmaceutical sector, the importance of sterile fill-finish capabilities is at an all-time high. PCI Pharma Services stands at the vanguard of these technological advances, seizing the moment with cutting-edge facilities and strategic growth initiatives. The
